Changes in Expression of Signal Transduction Proteins in T Lymphocytes of Patients with Leprosy

ABSTRACT Advanced stages of mycobacterial diseases such as leprosy and tuberculosis are characterized by a loss of T-cell function. The basis of this T-cell dysfunction is not well understood. The present report demonstrates major alterations in the expression of signal transduction molecules in T cells of leprosy patients. These alterations were most frequently observed in lepromatous leprosy (LL) patients. Of 29 LL patients, 69% had decreased T-cell receptor ζ-chain expression, 48% had decreased p56lck tyrosine kinase, and 63% had a loss of nuclear transcription factor NF-κB p65. An electrophoretic mobility shift assay with the gamma interferon core promoter region revealed a loss of the Th1 DNA-binding pattern in LL patients. In contrast, tuberculoid leprosy patients had only minor signal transduction alterations. These novel findings might improve our understanding of the T-cell dysfunction observed in leprosy and other infectious diseases and consequently might lead to better immunologic evaluation of patients.

[1]  M. Ochoa,et al.  LEPROMATOUS AND TUBERCULOID LEPROSY: CLINICAL PRESENTATION AND CYTOKINE RESPONSES , 1996, International journal of dermatology.

[2]  M. Pfreundschuh,et al.  T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. , 1996, Blood.

[3]  T. Whiteside,et al.  Alterations in expression and function of signal-transducing proteins in tumor-associated T and natural killer cells in patients with ovarian carcinoma. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[4]  D. Longo,et al.  Alterations in T cell receptor and signal transduction molecules in melanoma patients. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  V. Ramesh,et al.  Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. , 1995, Immunology.

[6]  A. Lichtman,et al.  Differentiation of the T helper phenotypes by analysis of the methylation state of the IFN-gamma gene. , 1994, Journal of immunology.

[7]  J. Haas,et al.  Tolerance to lipopolysaccharide involves mobilization of nuclear factor kappa B with predominance of p50 homodimers. , 1994, The Journal of biological chemistry.

[8]  R L Modlin,et al.  Th1-Th2 paradigm: insights from leprosy. , 1994, The Journal of investigative dermatology.

[9]  D. Longo,et al.  Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy. , 1994, Cancer research.

[10]  A. Singer,et al.  Differential effects of zeta and eta transgenes on early alpha/beta T cell development , 1994, The Journal of experimental medicine.

[11]  P. Fields,et al.  Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  S. Romagnani,et al.  The role of TH1 and TH2 subsets in human infectious diseases. , 1994, Trends in microbiology.

[13]  D. Longo,et al.  Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma. , 1993, Cancer research.

[14]  M. Matsuda,et al.  Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. , 1993, Cancer research.

[15]  M. Grilli,et al.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. , 1993, International review of cytology.

[16]  M. Clerici,et al.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection. , 1993, Immunology today.

[17]  D. Longo,et al.  Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. , 1992, Science.

[18]  John Calvin Reed,et al.  Anergic Th1 cells express altered levels of the protein tyrosine kinases p56lck and p59fyn. , 1992, Journal of immunology.

[19]  A. Israël,et al.  The precursor of NF-κB p50 has IκB-like functions , 1992, Cell.

[20]  A. Sica,et al.  The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Weinberg,et al.  Defining protective responses to pathogens: cytokine profiles in leprosy lesions. , 1991, Science.

[22]  D. Scollard.  Inside the skin: the local immune and inflammatory milieu in leprosy. , 1991, The American journal of tropical medicine and hygiene.

[23]  B. Bloom,et al.  On the mechanism of human T cell suppression. , 1989, International immunology.

[24]  R. Locksley,et al.  Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets , 1989, The Journal of experimental medicine.

[25]  R. Coffman,et al.  Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens , 1988, The Journal of experimental medicine.

[26]  J. Convit,et al.  Learning from lesions: patterns of tissue inflammation in leprosy. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  J. Lippincott-Schwartz,et al.  Failure to synthesize the T Cell CD3-ζ chain: Structure and function of a partial T cell receptor complex , 1988, Cell.

[28]  M. O. Landázuri,et al.  FAMILIAL DEFECT OF CD3 (T3) EXPRESSION BY T CELLS ASSOCIATED WITH RARE GUT EPITHELIAL CELL AUTOANTIBODIES , 1986, The Lancet.

[29]  B. Bloom,et al.  Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions , 1986, Nature.

[30]  T. Rea.  Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy. , 1983, Clinical and experimental immunology.

[31]  R. Steinman,et al.  The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. , 1982, The New England journal of medicine.

[32]  R. Steinman,et al.  The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes. , 1982, The New England journal of medicine.

[33]  T. Davey.  WHO EXPERT COMMITTEE ON LEPROSY, 5TH REPORT , 1977 .

[34]  Ridley Ds,et al.  Classification of leprosy according to immunity. A five-group system. , 1966 .

[35]  D. Ridley,et al.  Classification of leprosy according to immunity. A five-group system. , 1966, International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association.